In 2000, more than a quarter of the world's adult population, totaling nearly 1 billion people, were estimated to have hypertension-a figure that is projected to increase to 29% (1.5 billion) in 2025. 5 Worldwide, it is the leading risk factor for cardiovascular disease (CVD) and accounts for >13% (7 million) of deaths each year, as well as a substantial amount of disability.
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and projected estimates of the burden of disease because of SBP, we performed a systematic review with meta-analysis of prospective cohort studies of the sex-specific associations between SBP with stroke and IHD, both overall and, where data allowed, by major subgroups.
Methods

Search Strategy and Selection Criteria
A systematic search was performed at PubMed MEDLINE (www. ncbi.nlm.nih.gov) on March 21, 2012 . The following MeSH search terms were used: "Prospective Studies" OR "Longitudinal Studies" OR "Cohort Studies" AND "Cerebrovascular Disorders" OR "Myocardial Ischemia" OR "Coronary Artery Disease" AND "Female" OR "Women" AND "Male" OR "Men" OR "Sex" AND "Hypertension" OR "Blood Pressure." References were scanned to identify other potentially relevant studies. Studies were included if they provided relative risks (RRs; or equivalents) of the association between SBP and stroke or IHD separately for women and men. Studies were excluded if they had not adjusted for at least age, did not report a means of estimation of the variance around the point estimate, and were performed in populations that predominantly included individuals with a history of CVD or other underlying pathological disorders (eg, diabetes mellitus, renal disease, or cancer). Where possible, the following data at study baseline were extracted from each report: year and country of study, study size, proportion of women, age range (years), the number of fatal and nonfatal IHD and stroke events, the average length of follow-up (years), mean baseline SBP and diastolic BP, and adjustment variables. Any discrepancies in study selection or data extraction were resolved by mutual consent among the 3 authors. In addition, the authors had access to individual participant data from 4 studies: the Scottish Heart Health Extended Cohort (SHHEC) study; the APCSC (comprising 44 individual cohorts); the National Health and Nutrition Examination Survey III (NHANES III) 13-year follow-up; and the Atherosclerosis Risk in Communities (ARIC) study.
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Statistical Analysis
For each study, the sex-specific RRs for fatal and nonfatal stroke and IHD for each 10 mm Hg increment in SBP and 95% confidence intervals (CIs) were obtained to estimate the women:men ratio of RRs (RRRs) and 95% CIs.
14 These RRRs were computed separately for studies with only age-adjusted estimates and then for those studies with multiple-adjusted estimates. After log transformation of studyspecific estimates, pooled estimates were obtained using random effects models. The inverse of the variance of the log RRR was used to weigh studies according to an estimate of statistical size. 15 The primary outcomes of this study were the multiple-adjusted RRRs of stroke and IHD per 10 mm Hg increment in SBP. A series of prespecified sensitivity analyses were conducted: the RRR adjusted only for age; analysis restricted to fatal events; and a comparison of the RRR by region (Asia versus other). Also, using the individual participant data at our disposal, the RRRs for stroke and IHD in the following age groups were derived: 40 to 49, 50 to 59; 60 to 69; 70 to 79; and 80 to 89 years. 6 Finally, where information was available on stroke subtypes, we evaluated whether there was a sex difference in the RRR for either ischemic or hemorrhagic stroke.
The I 2 statistic was used to estimate the percentage of variability between studies because of between-study heterogeneity. 16, 17 Random effects meta-regression analyses were used to assess whether duration of study follow-up, baseline study year, or sex differences in absolute levels of SBP contributed to heterogeneity between studies. The presence of publication bias was graphically examined using funnel plots, plotting the natural log of the RRR against its SE. All analyses were performed using Stata version 11.0.
Results
The systematic search identified 4577 articles that were subsequently examined on title and abstract. Of these, 93 articles were selected which reported on the association between SBP and the risk of stroke or IHD (Figure 1 ). After full-text evaluation, 20 articles were selected that provided information from 77 cohorts on sex differences in the association between SBP and stroke or IHD (Tables 1 and 2) . [18] [19] [20] [21] [22] [23] [24] [25] [26] [27] [28] [29] [30] [31] [32] [33] [34] [35] [36] [37] Individual participant data from ARIC, 11 NHANES III, 10 APCSC, 13 and SHHEC 12 were subsequently added to these published results, giving a total of 24 studies comprising 124 prospective cohorts (Table 1) . Overall, data from 1197 472 individuals (44% women) in 
Sex-Specific Association Between SBP and Stroke Risk
The primary analysis on the multiple-adjusted association between SBP and stroke included data from 97 cohorts with 990 138 (83%) individuals (43% women) and 20 752 strokes. The pooled multiple-adjusted RRs for a 10-mm Hg increment in SBP showed a 23% (95% CI, 1.20; 1.25) increased risk for stroke in women and a 24% (95% CI, 1.20; 1.28) increased risk for stroke in men ( Figure I in the online-only Data Supplement).
There was no evidence of a sex difference in the association between SBP and stroke; the pooled multiple-adjusted RRR of stroke for a 10-mm Hg increase in SBP was 0.98 (95% CI, 0.96; 1.01; P=0.13; Figure 2 ) with no evidence of significant between-study heterogeneity (I 
Sensitivity Analyses
Meta-regression showed no effect of duration of follow-up (P=0.48), of baseline study year (P=0.56), or of the ratio of the mean SBP (women to men) in the cohorts (P=0. 
Meta-regression indicated that the RRR for IHD was not affected by duration of follow-up (P=0.09), by baseline study year (P=0. 
Discussion
Findings from this meta-analysis of ≈1.2 million individuals and >50 000 events unequivocally demonstrate the broadly similar nature of the association between SBP and risk of IHD and stroke in women and men. In the overall analysis, and after consideration of other major cardiovascular risk factors, every 10 mm Hg increment in SBP was associated with a ≈15% increased risk of IHD and a ≈25% increased risk of stroke, in both women and men.
Globally, elevated SBP levels are world's leading cause of total mortality and a major determinant of long-term disability. 1, 5 Results from previous large-scale studies have shown conflicting results on the presence of a sex difference in the relationship between SBP and vascular outcomes. [6] [7] [8] [9] Given the enormous burden caused by SBP increments, addressing the potential sex difference in the impact of SBP on cardiovascular outcomes is of major importance from both a clinical and public health perspective for several reasons. First, any significant differences between women and men in how risk factors are associated with CVD could have implications for the treatment and management of these risk factors. Second, current and projected estimates for the burden of disease uniformly rely on a single hazard ratio for both women and men in the ascertainment of population attributable fractions. 38 These estimates are used to inform the decision-making process in the allocation of health care resources, worldwide, and, therefore, it is essential that the estimates of the burden of disease are as accurate as the data allow. 5 Finally, findings of sex differences in the association between risk factors and CVD could provide an impetus for targeted interventions aimed at reducing the prevalence of these risk factors. 39 Strong evidence exists to indicate substantial sex differences in CVD risk factors, such as smoking and diabetes mellitus with risk of IHD. 14, 40 For example, compared with those without diabetes mellitus, women with diabetes mellitus are at double the risk of mortality from IHD compared with men largely irrespective of other risk factors. 40 For smoking, a similar sex interaction has been reported; compared with nonsmokers, women who smoke have 25% greater risk of IHD compared with men who smoke.
14 These data would suggest that estimates of the burden of IHD in women because of these risk factors should be revised upward to accommodate the greater excess hazard observed in women compared with men. For SBP, there was no evidence from this current study to indicate any sex difference with cardiovascular risk and, therefore, current and projected estimates for the global burden of SBP-related IHD and stroke remain valid.
The main difference between the current meta-analysis and an earlier report from the PSC is that this current meta-analysis included only those studies that included both women and men, whereas PSC additionally included same sex studies. 6 This is a potentially important distinction; it is possible, for example, that the association between SBP and IHD or stroke in 1 population of elderly men is likely to yield slightly different effect estimates compared with a study of middle-aged women, even if there is no real difference, because of differences in the background risk of the study population. In contrast, comparing the association between SBP and cardiovascular outcomes among women and men from the same study, as was done in the current review, affords better control for known and unknown confounding factors specific to that study. Yet, although study methodology was different, the main conclusion of both the present meta-analysis and the PSC is that the effects of sex in the SBP-induced risk for CVD are not substantial.
The relative effects of increments in SBP on cardiovascular outcomes between women and men were investigated in this study. The blood pressure-attributable risk of CVD in women and men depends on both sex differences in RRs and sex differences in the prevalence of high SBP. Because we have shown that the RRs are very similar, the only factor affecting the comparative burden must be the prevalence of high SBP. Men typically have higher SBP levels than women, and SBP rises more steeply in aging women compared with aging men. 41 Although hypertension is more prevalent among men than among women at younger ages, these trends seem to reverse with aging, as suggested by the current rates in the United States where >75% of women >75 years are hypertensive compared with >65% of men. 42 In addition, although a slight decline in global population mean levels of absolute SBP has been recently reported, these trends vary importantly across women and men living in different regions in the world. 43 Large decreases in SBP levels have been reported in women and men living in high-income countries, whereas mean SBP levels are currently the highest, and are still rising, particularly in women, living in low-and middle-income countries. 43 As the relative impact of SBP is the same, such discrepancies in absolute SBP levels are likely to have significant implications for the contribution of SBP increments to the burden of CVD in women and men at regional level, the largest burden to be expected in those regions with the highest SBP levels. Effective preventive actions to control and reverse current upward trends or to accelerate the falling trends, such as lower intake of dietary salt, higher intake of fruits and vegetables, weight loss, and use of blood pressurelowering therapies should thus be targeted at all individuals. 44, 45 Moreover, special attention should be paid to those living in low-and middle-income countries, where major increments in the burden of CVD are to be expected. These expected increments are not only because of major health transitions, but also in part because of the effects of population growth, a higher life expectancy, and a low level of awareness, treatment, and control of hypertension in these countries. 4, 46, 47 Although this meta-analysis provides the most comprehensive assessment of possible sex differences in the association between SBP with IHD and stroke, there are some limitations. First, we were not able to adjust properly for baseline differences in confounding factors both between and within studies which could explain the small sex difference observed in some subgroups. However, despite the likely disparities in cardiovascular risk profile, between women and men and between cohorts, the results were remarkably consistent across an extensive range of sensitivity analyses. Second, there was some heterogeneity across studies in study end point and duration of follow-up that may have affected our results to some extent. Yet, analyses stratified on level of adjustment and end point definition, and meta-regression analyses on study duration, baseline study year, and ratio of mean SBP did not provide any evidence of a substantial effect of these differences on the results.
In conclusion, elevated levels of SBP are a major risk factor for stroke and IHD in both women and men. This study unequivocally demonstrates the broadly similar impact of SBP increments on cardiovascular outcomes in both sexes. Figure III: Graph of meta-regression analysis of data in Figure 2 on log-transformed ratio of relative risks for each study (lnRRR) against the duration of follow-up in years. Each circle represents one study and the circle sizes depends on the precision of each estimate (the inverse of its within-study variance).
Figure IV: Graph of meta-regression analysis of data in Figure 2 on log-transformed ratio of relative risks for each study (lnRRR) against the baseline study year. Each circle represents one study and the circle sizes depends on the precision of each estimate (the inverse of its within-study variance).
Figure V: Graph of meta-regression analysis of data in Figure 2 on log-transformed ratio of relative risks for each study (lnRRR) against the ratio of mean systolic blood pressure (women to men). Each circle represents one study and the circle sizes depends on the precision of each estimate (the inverse of its within-study variance). Figure VIII: Age-adjusted women to men relative risk ratio for ischemic heart disease for each 10mmHg increase in systolic blood pressure. A list of study abbreviations is provided in Table 2 .
Figure IX: Multiple-adjusted relative risk for ischemic heart disease in women and men for each 10mmHg increase in systolic blood pressure. A list of study abbreviations is provided in Table 2 . Figure 3 on log-transformed ratio of relative risks for each study (lnRRR) against the duration of follow-up in years. Each circle represents one study and the circle sizes depends on the precision of each estimate (the inverse of its within-study variance).
Figure XII: Graph of meta-regression analysis of data in Figure 3 on log-transformed ratio of relative risks for each study (lnRRR) against the baseline study year. Each circle represents one study and the circle sizes depends on the precision of each estimate (the inverse of its within-study variance).
Figure XIII: Graph of meta-regression analysis of data in Figure 3 on log-transformed ratio of relative risks for each study (lnRRR) against the ratio of mean systolic blood pressure (women to men). Each circle represents one study and the circle sizes depends on the precision of each estimate (the inverse of its within-study variance).
Figure XIV: Relative risk ratio for ischemic heart disease by 10mmHg increase in systolic blood pressure in sensitivity analyses
Figure XV: Age-adjusted relative risk for ischemic heart disease in women and men for each 10mmHg increase in systolic blood pressure. A list of study abbreviations is provided in Table 2 .
Figure XVI: Age-adjusted women to men relative risk ratio for ischemic heart disease for each 10mmHg increase in systolic blood pressure. A list of study abbreviations is provided in Table 2 . 
